A real-life study of patients with severe asthma and EGPA treated with anti- IL5R

被引：0
|
作者：
Muemmler, C. [1 ]
Mertsch, P. [1 ]
Barnikel, M. [1 ]
Schoenermarck, U. [2 ]
Schulze-Koops, H. [2 ]
Behr, J. [1 ]
Kneidinger, N. [1 ]
Milger, K. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 5, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 4, Munich, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 337
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [41] Changing between anti-IL5 and anti-IL5 receptor treatments. A real-life study
    Bjerrum, Anne Sofie
    Skjold, Tina
    Andersen, Helle
    Pedersen, Lene
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [42] Predictors of new-onset EGPA in patient with severe asthma treated with anti IL-4/13
    Insalata, Greta
    Bracciali, Alberto
    Bentivegna, Elisa
    Catalisano, Alessia
    Marinato, Martina Maria
    Girolamo, Rubina Giulia
    Allegrini, Chiara
    Marzi, Chiara
    Lavorini, Federico
    Camiciottoli, Gianna
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [43] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [44] REAL WORD EFFECTIVENESS OF ANTI IL-5/IL-5R THERAPIES IN SEVERE ASTHMA WITH FUNGAL SENSITISATION
    Dhariwal, J.
    Hearn, A.
    Kavanagh, J.
    D'Ancona, G.
    Roxas, C.
    Green, L.
    Thomson, L.
    Fernandes, M.
    Kent, B. D.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A141 - A142
  • [45] Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real-life multicentre study (BIONIGE)
    Contoli, Marco
    Santus, Pierachille
    Menzella, Francesco
    Rocchi, Cindy
    Radovanovic, Dejan
    Baraldi, Federico
    Martelli, Chiara
    Casanova, Serena
    Barbetta, Carlo
    Micheletto, Claudio
    Scichilone, Nicola
    Beghe, Bianca
    Carpagnano, Elisiana
    Papi, Alberto
    CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (04)
  • [46] Vitamin D status and the response of anti- IL 5 drugs in severe asthma.
    Aldoseri, Alya Salman
    Hussein, Isra
    Hegarty, Suzanne
    Delagua, Isalynne
    Cormican, Liam
    Faul, John
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [47] Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
    Scioscia, Giulia
    Tondo, Pasquale
    Nolasco, Santi
    Pelaia, Corrado
    Carpagnano, Giovanna Elisiana
    Caiaffa, Maria Filomena
    Valenti, Giuseppe
    Maglio, Angelantonio
    Papia, Francesco
    Triggiani, Massimo
    Crimi, Nunzio
    Pelaia, Girolamo
    Vatrella, Alessandro
    Barbaro, Maria Pia Foschino
    Crimi, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [48] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    A. Padilla-Galo
    A. J. García-Ruiz
    R. Ch. Levy Abitbol
    C. Olveira
    F. Rivas-Ruiz
    N. García-Agua Soler
    M. Pérez Morales
    B. Valencia Azcona
    B. Tortajada-Goitia
    I. Moya-Carmona
    A. Levy-Naon
    Respiratory Research, 22
  • [49] Dupilumab is effective in real-life severe asthma patients with smoking history
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Idzko, Marco
    Breyer-Kohansal, Robab
    Pohl, Wolfgang
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [50] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    Padilla-Galo, A.
    Garcia-Ruiz, A. J.
    Levy Abitbol, R. Ch.
    Olveira, C.
    Rivas-Ruiz, F.
    Garcia-Agua Soler, N.
    Perez Morales, M.
    Valencia Azcona, B.
    Tortajada-Goitia, B.
    Moya-Carmona, I.
    Levy-Naon, A.
    RESPIRATORY RESEARCH, 2021, 22 (01)
12345